REQUEST A DEMO
Total
USD $0.00
Search more companies

Comprifarm S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Comprifarm S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Comprifarm S.A. is based in Ecuador. The head office is in Guayaquil. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on July 17, 2014. Comprifarm S.A. currently employs 24 (2021) people. The company’s latest financial report indicates a net sales revenue increase of 31.48% in 2022. Over the same period, its total assets grew by 19.22%. In 2022, Comprifarm S.A.’s net profit margin increased by 1.19%.

Headquarters
Transversal 8 2369, Calle Publica Bldg.
Guayaquil; Guayas;

Contact Details: Purchase the Comprifarm S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Comprifarm S.A. report to view the information.
Outstanding Shares:
Purchase the Comprifarm S.A. report to view the information.
Registered Capital:
Purchase the Comprifarm S.A. report to view the information.
Incorporation Date:
July 17, 2014
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Comprifarm S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
31.48%
Total operating revenue
29.94%
Operating profit (EBIT)
32.61%
EBITDA
29.62%
Net Profit (Loss) for the Period
146.18%
Total assets
19.22%
Total equity
36.47%
Operating Profit Margin (ROS)
0.03%
Net Profit Margin
1.19%
Return on Equity (ROE)
20.05%
Debt to Equity Ratio
-13.42%
Quick Ratio
0.04%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?